TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Biocon Limited ( (IN:BIOCON) ) is now available.
Biocon Limited has announced its Q2 FY26 earnings call, scheduled for November 12, 2025. This presentation is part of the company’s regulatory compliance with the Securities and Exchange Board of India. The earnings call is expected to provide insights into Biocon’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.
More about Biocon Limited
Biocon Limited operates in the biotechnology industry, focusing on the development and manufacturing of biopharmaceuticals. The company is known for its innovative solutions in the healthcare sector, particularly in the areas of biosimilars, generics, and novel biologics, serving markets globally.
Average Trading Volume: 89,211
Technical Sentiment Signal: Strong Buy
Current Market Cap: 507.3B INR
Find detailed analytics on BIOCON stock on TipRanks’ Stock Analysis page.